O'Donnell MA - Search Results

1

Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ.

Rosevear HM, Lightfoot AJ, Birusingh KK, Maymí JL, Nepple KG, O'Donnell MA; National BCG/Interferon Investigator Group. Rosevear HM, et al. J Urol. 2011 Sep;186(3):817-23. doi: 10.1016/j.juro.2011.04.073. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788050 Clinical Trial.

2

Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro.

Fujimoto T, O'Donnell MA, Szilvasi A, Yang H, Duda RB. Fujimoto T, et al. Cancer Immunol Immunother. 1996 Jun;42(5):280-4. doi: 10.1007/s002620050283. Cancer Immunol Immunother. 1996. PMID: 8706049

3

Transitional cell carcinoma--tantalizing issues of tumor biology.

O'Donnell MA. O'Donnell MA. J Urol. 1996 Sep;156(3):961. doi: 10.1016/s0022-5347(01)65672-6. J Urol. 1996. PMID: 8709373 No abstract available.

4

Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.

Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA. Fujimoto T, et al. J Immunol. 1997 Jun 15;158(12):5619-26. J Immunol. 1997. PMID: 9190909

5

Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.

Chen L, Chen D, Block E, O'Donnell M, Kufe DW, Clinton SK. Chen L, et al. J Immunol. 1997 Jul 1;159(1):351-9. J Immunol. 1997. PMID: 9200473

6

Pharmacological biocompatibility between intravesical preparations of BCG and interferon-alpha 2B.

Downs TM, Szilvasi A, O'Donnell MA. Downs TM, et al. J Urol. 1997 Dec;158(6):2311-5. doi: 10.1016/s0022-5347(01)68241-7. J Urol. 1997. PMID: 9366382

7

Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis.

Jackson AM, Ivshina AV, Senko O, Kuznetsova A, Sundan A, O'Donnell MA, Clinton S, Alexandroff AB, Selby PJ, James K, Kuznetsov VA. Jackson AM, et al. J Urol. 1998 Mar;159(3):1054-63. J Urol. 1998. PMID: 9474231

8

Superficial bladder cancer: the role of interferon-alpha.

Belldegrun AS, Franklin JR, O'Donnell MA, Gomella LG, Klein E, Neri R, Nseyo UO, Ratliff TL, Williams RD. Belldegrun AS, et al. J Urol. 1998 Jun;159(6):1793-801. doi: 10.1016/s0022-5347(01)63160-4. J Urol. 1998. PMID: 9598463 Review.

9

Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.

Poppas DP, Pavlovich CP, Folkman J, Voest EE, Chen X, Luster AD, O'Donnell MA. Poppas DP, et al. Urology. 1998 Aug;52(2):268-75; discussion 275-6. Urology. 1998. PMID: 9697793

10

IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.

Luo Y, Chen X, Downs TM, DeWolf WC, O'Donnell MA. Luo Y, et al. J Immunol. 1999 Feb 15;162(4):2399-405. J Immunol. 1999. PMID: 9973521 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results